Additional file 3. Additional tables showing: average number of influenza associated disease states and DALYs with their 95% credible interval limits, (2010–2018) (table on sheet 1); average annual rate per 100,000 of influenza associated disease states with their 95% credible interval limits, (2010–2018) (table on sheet 2); average number of influenza associated health care utilisation events with their 95% credible interval limits, (2010–2018) (table on sheet 3); national cost of influenza associated illness across all ages, (2010–2018) (table on sheet 4); average annual costs and 95% credible intervals (CIs) per vaccination strategy in millions of USD (table on sheet 5); incremental cost-effectiveness ratio for influenza vaccination using total societal costs (table on sheet 6).

Dynamic transmission model, Economic evaluation, Cost-effectiveness, Influenza vaccine, Low- and middle-income countries, Vaccine timing, Vaccine target group